Production of Large Amounts of Hydrogen Peroxide by Human Tumor Cells

Cancer Research

Volumn 51, Issue 3, 1991, Pages 794-798

  Szatrowski, Ted P ^a   Nathan, Carl F ^a  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLDITHIOCARBAMIC ACID; DIPHENYLENEIODONIUM DERIVATIVE; ENZYME INHIBITOR; HYDROGEN PEROXIDE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

BREAST NEOPLASMS; COLONIC NEOPLASMS; DITIOCARB; FEMALE; FIBROBLASTS; HUMAN; HYDROGEN PEROXIDE; MELANOMA; NEOPLASMS; NEUROBLASTOMA; OVARIAN NEOPLASMS; PANCREATIC NEOPLASMS; SUPEROXIDES; SUPPORT, U.S. GOV'T, P.H.S.; TUMOR CELLS, CULTURED;

EID: 0026021362     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Babior, B. M. Oxygen-dependent microbial killing by phagocytes. N. Engl. J. Med., 298: 659-725, 1978.
2. Klebanoff, S. J. Antimicrobial mechanisms in neutrophilic polymorphonuclear leukocytes. Semin. Hematol., 12: 117-142, 1975.
3. Babior, B. M., Kipnes, R. S., and Curnutte, J. T. Biological defense mecha nisms: the production by leukocytes of Superoxide, a potential bactericidal agent. J. Clin. Invest., 52: 741-744, 1973.
4. Johnston, R. B., Jr., Lehmeyer, J. E., and Guthrie, L. A. Generation of Superoxide anian and chemiluminescence by human monocytes during phagocytosis and on contact with surface-bound immunoglobulin G. J. Exp. Med., 143: 1551-1556, 1976.
5. Reiss, M., and Roos, D. Differences in oxygen metabolism of phagocytosing monocytes and neutrophils. J. Clin. Invest., 61: 480-488, 1978.
6. Weiss, S. J., King, G. W., and LoBuglio, A. F. Superoxide generation by human monocytes and macrophages. Am. J. Hematol., 4: 1-8, 1978.
7. Kitagawa, S., Takaku, F., and Sakamoto, S. A comparison of the superoxidereleasing response in human polymorphonuclear leukocytes and monocytes. J. Immunol., 125: 359-364, 1980.
8. Nakagawara, A., Nathan, C. F., and Cohn, Z. A. Hydrogen peroxide metab olism in human monocytes during differentiation in vitro. J. Clin. Invest., 68: 1243-1252. 1981.
9. Segal, A. W. and Jones, O. T. G. Novel cytochrome b system in phagocytic vacuoles of human granulocytes. Nature (Lond.). 276: 515-517, 1978.
10. Cross, A. R., Jones. O. T. G., Harper, A. M., and Segal, A. W. Oxidationreduction properties of the cytochrome b found in the plasma-membrane fraction of human neutrophils. Biochem. J., 194: 599-606, 1981.
11. Royer-Pokora, B., Kunkel. L. M., Monaco, A. P., et al. Cloning the gene for an inherited human disorderachronic granulomatous diseaseaon the basis of its chromosomal location. Nature (Lond.), 322: 32-38, 1986.
12. Baud, L., Hagege, J., Sraer, J., Rondeau, E., Perez, J., and Ardaillou, R. Reactive oxygen production by cultured rat glomerular mesangial cells during phagocytosis is associated with stimulation of lipoxygenase activity. J. Exp. Med., 158:1836-1852, 1983.
13. Foerder, C. A., Klebanoff, S. J., and Shapiro, B. M. Hydrogen peroxide production, chemiluminescence, and the respiratory burst of fertilization: interrelated events in early sea urchin development. Proc. Natl. Acad. Sci. USA, 75:3183-3187. 1978.
14. Nakamura, Y., Ogihara, S., and Ohtaki. S. Activation by ATP of calciumdependent NADPH-oxidase generating hydrogen peroxide in thyroid plasma membranes. J. Biochem., 102: 1121-1132, 1987.
15. Marcus, A. Pathways of oxygen utilization by stimulated platelets and leukocytes. Semin. Hematol., 16: 188-195, 1979.
16. Matsubara, T., and Ziff. M. Increased Superoxide anianrelease from human endothelial cells in response to cytokines. J. Immunol., 137: 3295-3298, 1986.
17. Meier, B., Radeke. H. H., Selle, S., et al. Human fibroblasts release reactive oxygen species in response to interleukin-1 or tumour necrosis factor-α. Biochem. J., 263: 539-545. 1989.
18. Volkman, D. J., Buescher, E. S., Gallin, J. I., and Fauci, A. S. B cell lines as models for inherited phagocytic diseases: abnormal Superoxide generation in chronic granulomatous disease and giant granules in Chediak-Higashi syn drome. J. Immunol., 133: 3006-3009, 1984.
19. Kobayashi, S., Imajoh-Ohmi, S., Nakamura, M., and Kanegasaki, S. Occur rence of cytochrome b558 in B-cell lineage of human lymphocytes. Blood, 75: 458-461, 1990.
20. Aune. T. M., and Pogue, S. L. Inhibition of tumor cell growth by interferongamma is mediated by two distinct mechanisms dependent upon oxygen tension: induction of tryptophan degradation and depletion of intracellular nicotinamide adenine dinucleotide. J. Clin. Invest., 84: 863-875. 1989.
21. Leroyer, V., Werner, L., Shaughnessy. S., Goddard. G. J., and Orr, F. W. Chemiluminescence and oxygen radical generation by Walker carcinosarcoma cells following chemotactic stimulation. Cancer Res., 47: 4771-4775, 1987.
22. Shaughnessy, S., Buchanan, M. R., Turple. S., Richardson, M., and Orr, F. W. Walker carcinosarcoma cells damage endothelial cells by the generation of reactive oxygen species. Am. J. Pathol., 134: 787-796, 1989.
23. Houghton, A. N., Albino, A. P., Cordon-Cardo, C., Davis, L. J., and Eisinger, M. Cell surface antigens of human melanocytes and melanoma: expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J. Exp. Med., 467:197-212, 1988.
24. Carey, T. E., Takahashi, T., Resnick, L. A., Oettgen. H. F., and Old, L. J. Cell surface antigens of human malignant melanoma. I. Mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells. Proc. Natl. Acad. Sci. USA, 73: 3278-3282, 1967.
25. Eisinger, M. and Marko, O. Selective proliferation of normal human melan ocytes in vitro in the presence of Phorbol ester and cholera toxin. Proc. Natl. Acad. Sci. USA, 79: 2018-2022, 1982.
26. Fogh, J., and Trempe, G. New human tumor cell lines. In: J. Fogh (ed.), Human Tumor Cells in Vitro, pp. 115-159. New York: Plenum Press, 1975.
27. Dexter, D. L., Barbosa, J. A., and Calabresi, P. AyV-Dimethylformamideinduced alteration of cell culture characteristics and loss of tumorigenicity in cultured human colon carcinoma cells. Cancer Res., 39: 1020-1025, 1979.
28. Chen, W. H., Horoszewicz. S. J., Leong, S. S., et al. Human pancreatic adenocarcinoma: in vitro and in rim morphology of a new tumor line established from ascites. In Vitro. 15: 24-28, 1982.
29. Tan, M. H., Shimano, T., and Chu, T. M. Differential localization of human pancreas-cancer-associated antigen and carcinoembryonic antigen in homol ogous pancreatic tumoral xenograft. J. Nail. Cancer Inst., 67: 563-566, 1981.
30. Cheung, N. K. V., Saarinie, U. M., Neely, J. E., et al. Monoclonal antibodies to glycolipid antigen on human neuroblastoma cells. Cancer Res., 45: 2642-2649, 1985.
31. Munn, D. H. and Cheung, N. K. V. Phagocytosis of tumor cells by human monocytes cultured in recombinant macrophage colony-stimulating factor. J. Exp. Med., 772: 231-237, 1990.
32. O'Donnell-Tormey, J., DeBoer. C. J., and Nathan, C. F. Resistance of human tumor cells in vitro to oxidative cytolysis. J. Clin. Invest., 76: 80-86, 1985.
33. Fogh, J., Wright, W. C., and Loveless, J. D. Absence of HeLa cell contami nation in 169 cell lines derived from human tumors. J. Natl. Cancer Inst., 58: 209-214, 1977.
34. Bouchard, M.,Fuller, B. D., Vijayasaradhi. S., and Houghton, A. N. Induction of pigmentation in mouse fibroblasts by expression of human tyrosinase cDNA. J. Exp. Med., 169: 2029-2042, 1989.
35. Nathan, C. F. Neutrophil activation on biological surfaces: massive secretion of hydrogen peroxide in response to products of macrophages and lympho cytes. J. Clin. Invest., 80: 1550-1560, 1987.
36. De la Harpe, J., and Nathan. C. F. A semi-automated micro-assay for H2O: release by human blood monocytes and mouse peritoneal macrophages. J. Immunol. Methods, 78: 323-336, 1985.
37. Tsunawaki, S., and Nathan, C. F. Enzymatic basis of macrophage activation. J. Biol. Chem., 259: 4305-4312, 1984.
38. Ding, A. H., and Nathan, C. F. The measurement of cytochrome b559 in polymorphonuclear leukocytes and macrophages in the presence of hemoglo bin or mitochondrial cytochromes. Anal. Biochem., 175: 22-29, 1988.
39. Cross, A. R., and Jones, O. T. G. The effect of the inhibitor diphenyleneiodonium on the superoxade-generating system of neutrophils. Specific label ling of a component polypeptide of the oxidase. Biochem. J., 237: 111-116, 1986.
40. Heinecke. J. W., and Shapiro, B. M. Respiratory burst oxidase of fertilization. Proc. Natl. Acad. Sci. USA, 86: 1259-1263, 1989.
41. Nathan, C. F., Arrick, B. A., Murray, H. W., DeSantis. N. M., and Conn. Z. A. Tumor cell anti-oxidant defenses. Inhibition of the glutathione redox cycle enhances macrophage-mediated cytolysis. J. Exp. Med., 153:766-782,1980.
42. Birnboim, H. C. DNA strand breakage in human leukocytes exposed to a tumor promoter, Phorbol myristate acetate. Science (Washington DC), 215: 1247-1249, 1982.
43. Jackson. J. H., Gajewski, E., Schraufstatter, I., et al. Damage to the bases in DNA induced by stimulated human neutrophils. J. Clin. Invest., 84: 1644-1649, 1989.
44. Lewis, L. G., and Adams. D. O. Induction of 5,6-ring-saturated thymine bases in NIH-3T3 cells by Phorbol ester-stimulated macrophages: role of reactive oxygen intermediates. Cancer Res., 45: 1270-1275. 1985.
45. Weitberg, A. B., Weitzman, S. A., Destrempes, M., Latt, S. A., and Stessei, T. P. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N. Engl. J. Med., 308: 26-30. 1983.
46. Cifone, M. A., and Fidler, I. J. Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc. Natl. Acad. Sci. USA, 78: 6949-6952, 1981.
47. Megidish, T., and Mazurek, N. A mutant protein kinase C that can transform fibroblasts. Nature (Lond.), 342: 807-811, 1989.
48. Swaim, M. W., and Pizzo, S. V. Methionine sulfoxide and the oxidative regulation of plasma proteinase inhibitors. J. Leukocyte Biol., 43: 365-379, 1988.
49. Johnson. D., and Travis, J. The oxidative inactivation of human alpha-1- proteinase inhibitor. Further evidence for methionine at the reactive center. J. Biol. Chem., 254: 4022-4026, 1979.
50. Mullins, D. E., and Rohrlich, S. T. The role of proteinases in cellular invasiveness. Biochim. Biophys. Acta, 695: 177-214, 1983.
51. Daato,K., Andreasen, P. A., Grondahl-Hansen, J., Kristensen, P., Nielsen, L. S., and Skriver, L. Plasminogen activators, tissue degradation, and cancer. Adv. Cancer Res., 44: 139-266, 1985.
52. Ossowski, L., and Reich, E. Antibodies to plasminogen activator inhibit human tumor metastasis. Cell. 35: 611-619, 1983.